cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Abeona Therapeutics Inc
112 own
128 watching
Current Price
$2.52
$0
(0%)
logo-abeo
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
19.33M
52-Week High
52-Week High
9.355
52-Week Low
52-Week Low
2.34
Average Volume
Average Volume
0.2M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization19.33M
icon52-Week High9.355
icon52-Week Low2.34
iconAverage Volume0.2M
iconDividend Yield--
iconP/E Ratio--
What does the Abeona Therapeutics Inc do?
Abeona Therapeutics Inc., a biopharmaceutical company, focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The company offers MuGard, a mucoadhesive oral wound rinse for mucositis, stomatitis, aphthous ulcers, and traumatic ulcers; and ProctiGard, a mucoadhesive oral wound rinse for the treatment of rectal mucositis and radiation proctitis. Its lead program is an adeno-associated virus (AAV)-based gene therapy for sanfilippo syndrome. The company develops ABO-101 for Mucopolysaccharidosis (MPS) III, a sanfilippo syndrome Type B; ABO-102 for MPS III, a sanfilippo syndrome Type A; ABO-201 for juvenile batten disease; ABO-301 for fanconi anemia; and clustered, regularly interspaced short palindromic repeats (CRISPR)-CRISPR associated protein 9 AAV for rare blood diseases. It also develops PTB-101 salt diafiltration process (SDF) Alpha, a alpha1-proteinase inhibitor for chronic augmentation and maintenance therapy in adults with clinically evident emphysema due to severe deficiency of alpha1-proteinase inhibitor; and PTB-102 SDF IVIG, an intravenous immunoglobulin for autoimmune, infectious, and idiopathic diseases. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1989 and is based in Dallas, Texas.
Read More
How much money does Abeona Therapeutics Inc make?
News & Events about Abeona Therapeutics Inc.
Globe Newswire
8 months ago
Disposition of MPS programs to reduce operating expenses andextend projected cash runway into 2Q 2023 Focus R&D resources on EB-101 pivotal phase 3 VIITAL topline data expected in 3Q 2022 NEW YORK and CLEVELAND, May 13, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-...
Globe Newswire
9 months ago
NEW YORK and CLEVELAND, April 29, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced that preclinical data on AAV204, a novel adeno-associated virus (AAV) capsid from Abeonas in-licensed AIM capsid library, will be ...
Globe Newswire
9 months ago
NEW YORK and CLEVELAND, April 29, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy, today announced that it has entered into a securities purchase agreement with certain institutional investors to purchase 1,000,006 shares of Series...
Globe Newswire
10 months ago
NEW YORK and CLEVELAND, March 28, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that Vish Seshadri, Ph.D., Chief Executive Officer of Abeona Therapeutics, will participate in a panel discussion titled, Cell ...
Frequently Asked Questions
Frequently Asked Questions
What is Abeona Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Abeona Therapeutics Inc shares?
plus_minus_icon
How can I buy Abeona Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Abeona Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Abeona Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Abeona Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Abeona Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Abeona Therapeutics Inc?
plus_minus_icon
What percentage is Abeona Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Abeona Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.52
$0
(0%)
logo-abeo
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Finch Therapeutics Group Inc
Finch Therapeutics Group Inc
$0.50
$0.03 (6.13 %)
Angion Biomedica Corp
Angion Biomedica Corp
$0.72
$0.02 (2.86 %)
Humanigen Inc
Humanigen Inc
$0.17
$0.00 (0.59 %)
Forte Biosciences Inc
Forte Biosciences Inc
$1.00
$0.00 (0.00 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Finch Therapeutics Group Inc
Finch Therapeutics Group Inc
$0.50
$0.03 (6.13 %)
Angion Biomedica Corp
Angion Biomedica Corp
$0.72
$0.02 (2.86 %)
Humanigen Inc
Humanigen Inc
$0.17
$0.00 (0.59 %)
Forte Biosciences Inc
Forte Biosciences Inc
$1.00
$0.00 (0.00 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00